Blood clots in cancer patients: a long-term study
Part of Cancer, Heart & circulation clinical trials.
This study follows people who have both cancer and a blood clot. It aims to learn more about how these clots happen and how they are treated in cancer patients, so doctors can improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have active cancer or are getting cancer treatment
- You have had a blood clot (like in your leg or lung) in the last 2 years
- You are covered by Social Security or similar health insurance
- You can understand and agree to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects information about blood clot events in people with cancer. The goal is to better understand how often clots happen and what patterns they follow, which can help improve care.
This study looks at how to best treat blood clots in veins near the skin in people who also have active cancer. It will compare different treatment options to find what works best and is safest for you.
This study looks for “biomarkers,” or blood signs, that may help detect hidden (occult) cancer in people who recently had a blood clot in the leg or a lung clot. It may help doctors catch cancer earlier by improving detection after venous thromboembolism.
This study looks at whether doctors can predict blood clots in people with certain cancers who are receiving chemotherapy. If you have ovarian, lung, stomach, or pancreatic cancer and are starting chemotherapy, you may be able to join and help improve clot prevention.
This study looks at how well blood thinners work in people with cancer and a recent blood clot. It measures the risk of bleeding by checking certain blood clotting factors.
This study follows people who have had a vein blood clot (or related venous clot) to understand what factors may make the clot happen again. It may help clinicians find better ways to prevent repeat clots.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.